Literature DB >> 29284090

Systematic Tuning of Fluoro-galectin-3 Interactions Provides Thiodigalactoside Derivatives with Single-Digit nM Affinity and High Selectivity.

Kristoffer Peterson1, Rohit Kumar2, Olof Stenström3, Priya Verma1, Prashant R Verma1, Maria Håkansson4, Barbro Kahl-Knutsson5, Fredrik Zetterberg6, Hakon Leffler5, Mikael Akke3, Derek T Logan2,4, Ulf J Nilsson1.   

Abstract

Symmetrical and asymmetrical fluorinated phenyltriazolyl-thiodigalactoside derivatives have been synthesized and evaluated as inhibitors of galectin-1 and galectin-3. Systematic tuning of the phenyltriazolyl-thiodigalactosides' fluoro-interactions with galectin-3 led to the discovery of inhibitors with exceptional affinities (Kd down to 1-2 nM) in symmetrically substituted thiodigalactosides as well as unsurpassed combination of high affinity (Kd 7.5 nM) and selectivity (46-fold) over galectin-1 for asymmetrical thiodigalactosides by carrying one trifluorphenyltriazole and one coumaryl moiety. Studies of the inhibitor-galectin complexes with isothermal titration calorimetry and X-ray crystallography revealed the importance of fluoro-amide interaction for affinity and for selectivity. Finally, the high affinity of the discovered inhibitors required two competitive titration assay tools to be developed: a new high affinity fluorescent probe for competitive fluorescent polarization and a competitive ligand optimal for analyzing high affinity galectin-3 inhibitors with competitive isothermal titration calorimetry.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29284090     DOI: 10.1021/acs.jmedchem.7b01626

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  16 in total

1.  Quinoline-Pyrazole Scaffold as a Novel Ligand of Galectin-3 and Suppressor of TREM2 Signaling.

Authors:  Moustafa Gabr; Ashfaq Ur Rehman; Hai-Feng Chen
Journal:  ACS Med Chem Lett       Date:  2020-08-11       Impact factor: 4.345

2.  Discovery and Optimization of the First Highly Effective and Orally Available Galectin-3 Inhibitors for Treatment of Fibrotic Disease.

Authors:  Fredrik R Zetterberg; Alison MacKinnon; Thomas Brimert; Lise Gravelle; Richard E Johnsson; Barbro Kahl-Knutson; Hakon Leffler; Ulf J Nilsson; Anders Pedersen; Kristoffer Peterson; James A Roper; Hans Schambye; Robert J Slack; Susan Tantawi
Journal:  J Med Chem       Date:  2022-09-26       Impact factor: 8.039

3.  Galectin binding to cells and glycoproteins with genetically modified glycosylation reveals galectin-glycan specificities in a natural context.

Authors:  Mathias Ingemann Nielsen; John Stegmayr; Oliver C Grant; Zhang Yang; Ulf J Nilsson; Irene Boos; Michael C Carlsson; Robert J Woods; Carlo Unverzagt; Hakon Leffler; Hans H Wandall
Journal:  J Biol Chem       Date:  2018-11-01       Impact factor: 5.157

4.  Synthesis of tricyclic carbohydrate-benzene hybrids as selective inhibitors of galectin-1 and galectin-8 N-terminal domains.

Authors:  Chunxia Wu; Can Yong; Qiuju Zhong; Zhouyu Wang; Ulf J Nilsson; Yuanyuan Zhang
Journal:  RSC Adv       Date:  2020-05-22       Impact factor: 3.361

Review 5.  Galectins as Molecular Targets for Therapeutic Intervention.

Authors:  Ruud P M Dings; Michelle C Miller; Robert J Griffin; Kevin H Mayo
Journal:  Int J Mol Sci       Date:  2018-03-19       Impact factor: 5.923

6.  Aminopyrimidine-galactose hybrids are highly selective galectin-3 inhibitors.

Authors:  Alexander Dahlqvist; Fredrik R Zetterberg; Hakon Leffler; Ulf J Nilsson
Journal:  Medchemcomm       Date:  2019-05-13       Impact factor: 3.597

7.  Extracellular and intracellular small-molecule galectin-3 inhibitors.

Authors:  John Stegmayr; Fredrik Zetterberg; Michael C Carlsson; Xiaoli Huang; Gunjan Sharma; Barbro Kahl-Knutson; Hans Schambye; Ulf J Nilsson; Stina Oredsson; Hakon Leffler
Journal:  Sci Rep       Date:  2019-02-18       Impact factor: 4.379

8.  Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer's disease.

Authors:  Antonio Boza-Serrano; Rocío Ruiz; Raquel Sanchez-Varo; Juan García-Revilla; Yiyi Yang; Itzia Jimenez-Ferrer; Agnes Paulus; Malin Wennström; Anna Vilalta; David Allendorf; Jose Carlos Davila; John Stegmayr; Sebastian Jiménez; Maria A Roca-Ceballos; Victoria Navarro-Garrido; Maria Swanberg; Christine L Hsieh; Luis M Real; Elisabet Englund; Sara Linse; Hakon Leffler; Ulf J Nilsson; Guy C Brown; Antonia Gutierrez; Javier Vitorica; Jose Luis Venero; Tomas Deierborg
Journal:  Acta Neuropathol       Date:  2019-04-20       Impact factor: 17.088

9.  Structure and Energetics of Ligand-Fluorine Interactions with Galectin-3 Backbone and Side-Chain Amides: Insight into Solvation Effects and Multipolar Interactions.

Authors:  Rohit Kumar; Majda Misini Ignjatović; Kristoffer Peterson; Martin Olsson; Hakon Leffler; Ulf Ryde; Ulf J Nilsson; Derek T Logan
Journal:  ChemMedChem       Date:  2019-07-11       Impact factor: 3.466

Review 10.  1,2,3-Triazole-containing hybrids as leads in medicinal chemistry: A recent overview.

Authors:  Khurshed Bozorov; Jiangyu Zhao; Haji A Aisa
Journal:  Bioorg Med Chem       Date:  2019-07-04       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.